Replies to post #129798 on Biotech Values

[iwfal]

MNTA -

in all likelihood, MNTA’s ‘466 patent is no longer in play in the Lovenox patent trial.

Which Lovenox patent trial? Amphastar's or Teva's? Or both?

(I think 466 is still in play for Teva - but would agree it is very likely to be permanently out for Amphastar)